He said he felt "quite emotional" seeing the pictures of the first vaccination taking place, adding that the programme was starting across 70 hospitals in the UK.
Doria has frequently clashed over the vaccine with Bolsonaro, an aggressive China critic who has baselessly dismissed the Sinovac candidate as lacking credibility.
With two doses likely to be necessary, the contract means one and half million people in the country could be vaccinated, the government added in a statement.
Meanwhile, plans are reportedly being stepped up to ensure any complications arising from the end of the Brexit transition period on December 31 do not impact its roll-out.
In the first quarter of 2021, Oslo expects to receive a total of 2.5 million doses, covering 1.25 million people, pending approval of the vaccines from European regulators. Norway's population is 5.4 million.
British leaders said that, while they would love to get a jab themselves, priority had to be given to those most in need - the elderly, those in care homes and health workers.
Britain is the first Western country to approve a COVID-19 vaccine, a move that many see as a political coup for Prime Minister Boris Johnson's government.
Pfizer has agreed to deliver the first one million doses in the first quarter of 2021, with 1.7 million doses, 5.8 million and 4.3 million to follow in subsequent quarters, Muhyiddin said.
The Amsterdam-based EMA is carrying out "rolling reviews" designed to speed up vaccine approval times on three candidates: Pfizer-BioNTech, Moderna, and Oxford University-AstraZeneca.
The application to the U.S. Food and Drug Administration (FDA) comes just days after Pfizer and German partner BioNTech SE reported final trial results that showed the vaccine was 95% effective in preventing COVID-19 with no major safety concerns.
Pfizer and German partner BioNTech SE confirmed a deal was forthcoming in a statement on Thursday but did not disclose financial details.
In televised remarks, Netanyahu said the agreement marked "a great day for Israel" and added: "The goal is for the vaccine supply to start in January and increase in the months thereafter".
Pfizer and German partner BioNTech SE are the first drugmakers to release successful data from a large-scale clinical trial of a coronavirus vaccine.
We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records,
Pfizer Inc said on Friday it would apply for emergency use in the United States of its COVID-19 vaccine candidate being developed along with Germany's BioNTech SE as soon as a safety milestone.